U.S. needs clear policy on stem cell research, expert says

11/23/2010 | Philadelphia Inquirer, The

Congress needs to craft clear, comprehensive policy on research that uses stem cells derived from human embryos to end legal ambiguity surrounding such research, said John Gearhart, a stem cell pioneer and head of the University of Pennsylvania's Institute for Regenerative Medicine. An appeals court will conduct a hearing in December to discuss the legality of providing federal funding for embryonic stem cell research.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI